Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
4.12
-0.21 (-4.85%)
At close: Jun 06, 2025, 3:59 PM
4.19
1.70%
After-hours: Jun 06, 2025, 05:40 PM EDT
-4.85% (1D)
| Bid | 4.04 |
| Market Cap | 44.61M |
| Revenue (ttm) | 441K |
| Net Income (ttm) | 86.16M |
| EPS (ttm) | 118.98 |
| PE Ratio (ttm) | 0.03 |
| Forward PE | -0.87 |
| Analyst | Buy |
| Ask | 4.79 |
| Volume | 86,747 |
| Avg. Volume (20D) | 86,339 |
| Open | 4.42 |
| Previous Close | 4.33 |
| Day's Range | 4.10 - 4.35 |
| 52-Week Range | 3.39 - 16.00 |
| Beta | 0.71 |
About AVTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+11.93%
Avalo Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
9 months ago
+8.88%
Avalo Therapeutics shares are trading higher after BVF Partners disclosed in a 13G filing that it reported a 9.99% stake in the company.
